⌘K

Login Start Free

Home/Filings/4/0001578563-25-000322

4//SEC Filing

KAPLAN GILLA 4

Accession 0001578563-25-000322

CIK 0001534120other

View on SEC.gov Company Profile

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 4:30 PM ET

Size

5.5 KB

Accession

0001578563-25-000322

Insider Transaction Report

Form 4

Period: 2025-06-17

Avalo Therapeutics, Inc.AVTX

Director

Transactions

Award
Stock Option (Right to Buy)
2025-06-17+20,100→ 20,100 total
Exercise: $4.47Exp: 2035-06-17→ Common Stock (20,100 underlying)

Footnotes (1)

[F1]The stock option vests 100% on the first anniversary of the date of grant, subject to the Eligible Director's continued service on such vesting date.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother

Related Parties

1

filerCIK 0001247024

Filing Metadata

Form type: 4
Filed: Jun 17, 8:00 PM ET
Accepted: Jun 18, 4:30 PM ET
Size: 5.5 KB

View on SEC.gov